Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.45
-$0.03-6.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.95M | 2.28M | 1.32M | 2.88M | 1.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.22M | 2.79M | 2.27M | 3.91M | 2.95M |
| Operating Income | -2.22M | -2.79M | -2.27M | -3.91M | -2.95M |
| Income Before Tax | -2.15M | -2.61M | -2.35M | -3.71M | -3.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.15M | -2.61M | -2.35M | -3.71M | -3.05M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.15M | -2.61M | -2.35M | -3.71M | -3.05M |
| EBIT | -2.22M | -2.79M | -2.27M | -3.91M | -2.95M |
| EBITDA | -2.22M | -2.50M | -2.27M | -3.91M | -2.95M |
| EPS Basic | -0.43 | -0.94 | -1.05 | -3.29 | -7.60 |
| Normalized Basic EPS | -0.27 | -0.67 | -0.66 | -2.06 | -4.75 |
| EPS Diluted | -0.43 | -0.95 | -1.05 | -3.29 | -7.60 |
| Normalized Diluted EPS | -0.27 | -0.67 | -0.66 | -2.06 | -4.75 |
| Average Basic Shares Outstanding | 5.03M | 2.77M | 2.23M | 1.13M | 402.00K |
| Average Diluted Shares Outstanding | 5.03M | 2.77M | 2.23M | 1.13M | 402.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |